Clinical and immunomodulatory effects of combination immunotherapy with low-dose interleukin 2 and tumor necrosis factor alpha in patients with advanced non-small cell lung cancer: a phase I trial.
Year: 1991
Type: article
Study design: Clinical Trial
Source: PubMed
Authors: S C Yang, E A Grimm, D R Parkinson, J Carinhas, K D Fry, A Mendiguren-Rodriguez, J Licciardello, L B Owen-Schaub, W K Hong, J A Roth
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: National Institutes of Health
OpenAlex ID: W2151609804